Large-cap Consumer Staples company CVS Health has moved 1.8% so far today on a volume of 9,013,207, compared to its average of 7,432,865. In contrast, the S&P 500 index moved 1.0%.
CVS Health trades -4.59% away from its average analyst target price of $79.93 per share. The 22 analysts following the stock have set target prices ranging from $67.92 to $95.45, and on average have given CVS Health a rating of buy.
Anyone interested in buying CVS should be aware of the facts below:
-
CVS Health's current price is -20.1% below its Graham number of $95.42, which implies the stock has a margin of safety
-
CVS Health has moved -21.2% over the last year, and the S&P 500 logged a change of 24.0%
-
Based on its trailing earnings per share of 6.53, CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 11.7 while the S&P 500 average is 15.97
-
CVS has a forward P/E ratio of 9.8 based on its forward 12 month price to earnings (EPS) of $7.82 per share
-
The company has a price to earnings growth (PEG) ratio of 4.42 — a number near or below 1 signifying that CVS Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.32 compared to its sector average of 4.12
-
CVS Health Corporation provides health services in the United States.
-
Based in Woonsocket, the company has 219,000 full time employees and a market cap of $98.14 Billion. CVS Health currently returns an annual dividend yield of 3.2%.